Analyst consensus rating
Medtronic Analyst Rating: Buy
MDT is rated Buy by 25 analysts with a $98.44 target. As of 2026-08-26.
Direct answer
Medtronic's consensus rating is Buy.
25 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $98.44.
Forecast evidence checked August 26, 2026.
Get free Medtronic email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $91.14
- Average price target
- $98.44
- High price target
- $121.00
- Low price target
- $78.00
- Low target gap
- -14.4%
- Target upside
- +8%
- High target gap
- +32.8%
- Target range width
- 47.2%
- Consensus rating
- Buy
- Analysts
- 25
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Medtronic?
Medtronic has a verified Buy consensus. The same dataset has an average price target of $98.44.
How far are Medtronic's low and high targets from the recorded price?
The low target implies -14.4%, while the high target implies +32.8%.
How many analysts are included in Medtronic's consensus?
The verified consensus includes 25 analysts.
How is Medtronic's target upside or downside calculated?
The average target of $98.44 is divided by the recorded price of $91.14, then one is subtracted to produce +8%. This does not guarantee a future return.
When was Medtronic's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.